Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

Acquisitions (Tables)
12 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable The acquisition date fair value of common stock transferred is calculated below (in thousands, except share and per share amounts):
Common Stock Valuation
Shares of common stock issued as consideration
Stock price per share on closing date
$ 13.94 
Value of common stock issued as consideration
$ 13,940 
Issue discount due to lack of marketability
$ (697)
Fair value of common stock at December 10, 2018
$ 13,243 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The preliminary acquisition fair values below are presented as of December 10, 2018 (in thousands):

Current assets, including cash and cash equivalents of $1,381  $ 22,172 
Property and equipment  21,029 
Identifiable intangible assets  71,792 
Goodwill  50,873 
Long-term assets  170 
Total assets acquired  166,036 
Current liabilities  (10,769)
Long-term liabilities (1)  (15,265)
Net assets acquired  $ 140,002 

(1) Includes $14.7 million in deferred tax liabilities associated with tangible and intangible assets acquired.
Schedule Of Revenue And Earnings Table
The amount of revenue and earnings of Genoptix since the date of acquisition that are included in the consolidated statement of operations as of December 31, 2018 are as follows (in thousands):

For the period December 10, 2018
through December 31, 2018 
Revenue  $ 4,629 
Gross Margin  $ 2,600 
Net (Loss)  $ (334)
Business Acquisition, Pro Forma Information
The following unaudited pro forma information (in thousands) have been provided for illustrative purposes only and are not necessarily indicative of results that would have occurred had the Acquisition been in effect since January 1, 2017, nor are they necessarily indicative of future results.

Years ended December 31,
2018  2017
(as adjusted) 
Revenue  $ 367,988  $ 356,711 
Net income (loss) attributable to common stockholders  1,401  (42,930)
Income (loss) per share  $ 0.02  $ (0.53)
Basic  85,618  80,426 
Diluted  91,568  80,426